ASTN2
Basic information
Region (hg38): 9:116423112-117415070
Links
Phenotypes
GenCC
Source:
- autism spectrum disorder (Limited), mode of inheritance: AD
- intellectual disability (Limited), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
- Bardet-Biedl syndrome (29 variants)
- not provided (4 variants)
- Sarcotubular myopathy (2 variants)
- Bardet-Biedl syndrome 11 (1 variants)
- Myopathy (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ASTN2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 19 | 11 | 30 | |||
missense | 73 | 85 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 4 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 1 | 2 | 3 | |||
non coding | 33 | 18 | 343 | 207 | 12 | 613 |
Total | 33 | 18 | 419 | 235 | 29 |
Highest pathogenic variant AF is 0.0000131
Variants in ASTN2
This is a list of pathogenic ClinVar variants found in the ASTN2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-116425855-C-T | not specified | Uncertain significance (Aug 13, 2021) | ||
9-116425856-G-A | not specified | Uncertain significance (Jun 22, 2021) | ||
9-116425872-G-A | ASTN2-related disorder | Likely benign (Aug 08, 2019) | ||
9-116425875-C-T | ASTN2-related disorder | Likely benign (Jul 13, 2018) | ||
9-116425912-G-A | not specified | Uncertain significance (Nov 07, 2023) | ||
9-116425970-C-T | not specified | Uncertain significance (Aug 16, 2022) | ||
9-116425987-T-C | not specified | Uncertain significance (Dec 12, 2023) | ||
9-116425996-G-A | not specified | Uncertain significance (Dec 26, 2023) | ||
9-116426008-C-A | ASTN2-related disorder | Likely benign (Aug 18, 2018) | ||
9-116426021-C-T | not specified | Uncertain significance (May 03, 2023) | ||
9-116426026-C-T | not specified | Uncertain significance (Dec 07, 2022) | ||
9-116426027-G-T | Benign (Dec 31, 2019) | |||
9-116426050-C-T | not specified | Uncertain significance (Sep 16, 2021) | ||
9-116426068-C-T | not specified | Uncertain significance (Dec 27, 2022) | ||
9-116440600-C-A | ASTN2-related disorder | Benign (Oct 21, 2019) | ||
9-116440713-C-T | not specified | Uncertain significance (May 31, 2023) | ||
9-116440776-G-C | not specified | Uncertain significance (Apr 15, 2024) | ||
9-116440777-A-G | not specified | Uncertain significance (Oct 17, 2023) | ||
9-116440792-T-C | not specified | Uncertain significance (Aug 13, 2021) | ||
9-116442452-C-T | See cases | Uncertain significance (Aug 24, 2022) | ||
9-116487408-T-A | not specified | Uncertain significance (Sep 22, 2023) | ||
9-116487408-T-C | not specified | Uncertain significance (Dec 18, 2023) | ||
9-116487411-C-T | Benign (Dec 31, 2019) | |||
9-116487434-C-T | not specified | Uncertain significance (May 17, 2023) | ||
9-116487455-G-A | ASTN2-related disorder | Benign (Dec 31, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ASTN2 | protein_coding | protein_coding | ENST00000361209 | 22 | 989845 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.000294 | 125734 | 0 | 14 | 125748 | 0.0000557 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.16 | 603 | 689 | 0.876 | 0.0000417 | 8290 |
Missense in Polyphen | 2 | 1.1962 | 1.6719 | 16 | ||
Synonymous | -1.39 | 326 | 296 | 1.10 | 0.0000179 | 2627 |
Loss of Function | 6.12 | 8 | 58.6 | 0.137 | 0.00000291 | 671 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000239 | 0.000239 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.0000566 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000353 | 0.0000352 |
Middle Eastern | 0.0000566 | 0.0000544 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Mediates recycling of the neuronal cell adhesion molecule ASTN1 to the anterior pole of the cell membrane in migrating neurons. Promotes ASTN1 internalization and intracellular transport of endocytosed ASTN1 (By similarity). Selectively binds inositol-4,5-bisphosphate, inositol-3,4,5- trisphosphate and inositol-1,3,4,5-tetrakisphosphate, suggesting it is recruited to membranes that contain lipids with a phosphoinositide headgroup (Ref.6). {ECO:0000250|UniProtKB:Q80Z10, ECO:0000269|Ref.6}.;
Recessive Scores
- pRec
- 0.110
Intolerance Scores
- loftool
- 0.363
- rvis_EVS
- -2.27
- rvis_percentile_EVS
- 1.26
Haploinsufficiency Scores
- pHI
- 0.286
- hipred
- Y
- hipred_score
- 0.563
- ghis
- 0.571
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.366
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Astn2
- Phenotype
- integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan);
Gene ontology
- Biological process
- protein transport;establishment of body hair planar orientation;negative regulation of protein localization to cell surface
- Cellular component
- early endosome;late endosome;cell cortex;integral component of membrane;clathrin-coated vesicle;perikaryon;cell pole
- Molecular function
- calcium ion binding;inositol 1,3,4,5 tetrakisphosphate binding